16 results
·
19ms
·
Sources: EU EUDAMED, US FDA
MODIFICATION TO 3.0T SIGNA VH/I MAGNETIC RESONANCE SYSTEM
FDA 510(k)
FDA Class 2
·Radiology
Implant Prosthetics
FDA UDI
Preat Corporation·00842092103340·CAMLOG® Screw-Line-compatible 5.0mm Straight Mu...
KALORE™
FDA UDI
Gc America Inc.·D0470035751·KALORE™ Syringes (2 mL/4 g) OBW
KALORE™
FDA UDI
Gc America Inc.·14548161293099·KALORE™ Syringes (2 mL/4 g) OBW
DE11-3U Ultrasonic Probe(FDA)
FDA UDI
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.·06944904088419·
RHEUMATOID FACTOR TEST SYSTEM
FDA Adverse Event
Malfunction
·BECKMAN COULTER INC.·Product code DHR·July 12, 2011
INTER-OP DURASUL ACETABULAR INSERTS (4MM)
FDA 510(k)
FDA Class 2
·Orthopedic
GLOBAL ADVANTAGE EXTENDED HUMERAL HEAD
FDA 510(k)
FDA Class 2
·Orthopedic
ID NOW COVID-19 ASSAY
FDA Adverse Event
Malfunction
·ABBOTT DIAGNOSTICS SCARBOROUGH, INC.·Product code QJR·January 15, 2021
INSPIRA SMOOTH SILICONE GEL FILLED BREAST IMPLANT
FDA Adverse Event
Injury
·ALLERGAN (COSTA RICA)·Product code FTR·June 3, 2020
AED PRO
FDA Adverse Event
Malfunction
·ZOLL MEDICAL CORPORATION·Product code MKJ·February 7, 2013
AKREOS ADVANCED OPTICS ASPHERIC LENS
FDA Adverse Event
Injury
·BAUSCH + LOMB·Product code HQL·February 22, 2011
ABSOLUTE .035 SELF EXPANDING STENT SYSTEM
FDA Adverse Event
Injury
·ABBOTT VASCULAR-VASCULAR SOLUTIONS·Product code FGE·February 25, 2008
smiths medical portex Venn Reusable Tracheal Tube Introducer, 15Ch x 60cm, REF 14-504-17 and REF 14-504-17JP
FDA Enforcement
Class II
·Ongoing·Smiths Medical ASD, Inc.·December 4, 2024
Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·March 27, 2013
CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.
FDA Enforcement
Class I
·Ongoing·Smiths Medical ASD Inc.·August 14, 2024